TuHURA Biosciences, Inc. (HURA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 6.98M | 4.62M | 3.5M | 12.54M | 14.33M | 19.61M | 3.48M | 5.3M | 1.19M | 783K | 3.27M | 10.11M |
| Cash & Short-Term Investments | 6.3M | 3.62M | 2.7M | 8.51M | 6.22M | 12.66M | 3.02M | 4.46M | 658K | 216K | 1.53M | 9.82M |
| Cash Only | 6.3M | 3.62M | 2.7M | 8.51M | 6.22M | 12.66M | 3.02M | 4.46M | 658K | 216K | 1.53M | 9.82M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 214.7K | 3M | 95.55K | 222.7K | 258K | 334.44K | 103K | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 214.7K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | 1.12K | - | - | - | - | - | - |
| Other Current Assets | 367.51K | 1M | 386.77K | 1.03M | 702.16K | 316.35K | 0 | 500.97K | 425K | 567K | 1.74M | 290.87K |
| Total Non-Current Assets | 22.72M | 22.73M | 22.19M | 21.96M | 313.3K | 356.3K | 657K | 488.81K | 699K | 694K | 709K | 329.89K |
| Property, Plant & Equipment | 675.64K | 685.17K | 378.04K | 144.17K | 313.3K | 322.53K | 657K | 455.04K | 699K | 694K | 709K | 329.89K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 10.74M | 10.74M | 13.55M | 13.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 11.28M | 0 | 8.26M | 8.26M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 33.77K | 11.31M | 0 | 0 | 0 | 33.77K | 0 | 33.77K | 0 | 0 | 0 | 0 |
| Total Assets | 29.7M | 27.35M | 25.7M | 34.62M | 14.64M | 19.97M | 4.14M | 5.79M | 1.89M | 1.48M | 3.98M | 10.44M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 102.92% | 36.99% | 520.7% | - | 153.01% | 959.24% | 180.3% | -44.58% | -80.99% | -88.82% | -75.05% | - |
| Total Current Liabilities | 6.07M | 5.92M | 8.83M | 15.17M | 4.78M | 5.33M | 5.43M | 4.84M | 1.87M | 3.34M | 3.08M | 3.28M |
| Accounts Payable | 3.95M | 0 | 4.13M | 0 | 3.08M | 3.15M | 1.28M | 1.64M | 1.72M | 3M | 2.78M | 291.13K |
| Days Payables Outstanding | 15.16K | - | - | - | - | 11.57K | 4.59K | - | 14.47K | 17.73K | 9.33K | 8.95K |
| Short-Term Debt | 206.85K | 199.04K | 493.39K | 434K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 197.59K | 5.72M | 3.99M | 2.52M | 1.45M | 1.16M | 3.15M | 2.06M | 148K | 338K | 298K | 1.16M |
| Current Ratio | 1.15x | 0.78x | 0.40x | 0.83x | 3.00x | 3.68x | 0.64x | 1.09x | 0.63x | 0.23x | 1.06x | 3.09x |
| Quick Ratio | 1.15x | 0.78x | 0.40x | 0.83x | 3.00x | 3.64x | 0.64x | 1.09x | 0.63x | 0.23x | 1.06x | 3.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 447.99K | 501.55K | 84.98K | 0 | 0 | 42.7K | 24.45M | 7.01M | 179K | 167K | 166K | 0 |
| Long-Term Debt | 0 | 303.63K | 0 | 0 | 0 | 0 | 0 | 6.85M | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 250.07K | 0 | 0 | 0 | 0 | 42.7K | 0 | 164.59K | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 197.92K | 197.92K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | -1 | 0 | 84.98K | 0 | 0 | 0 | 24.45M | 0 | 179K | 167K | 166K | 0 |
| Total Liabilities | 6.51M | 6.42M | 8.92M | 15.17M | 4.78M | 5.37M | 2.44M | 11.85M | 2.05M | 3.5M | 3.25M | 3.28M |
| Total Debt | 456.93K | 502.67K | 577.73K | 558.97K | 164.59K | 202.54K | 0 | 7.16M | 0 | 0 | 0 | 110.02K |
| Net Debt | -5.84M | -3.12M | -2.12M | -7.95M | -6.06M | -12.45M | -3.02M | 2.69M | -658K | -216K | -1.53M | -9.71M |
| Debt / Equity | 0.02x | 0.02x | 0.03x | 0.03x | 0.02x | 0.01x | - | - | - | - | - | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -269.17x | -10.11x | -428.62x | - | - | -10.47x | -1.86x | -17.98x | - | - | - | - |
| Total Equity | 23.19M | 20.93M | 16.78M | 19.45M | 9.86M | 14.59M | 1.7M | -6.07M | -164K | -2.03M | 731K | 7.16M |
| Equity Growth % | 135.28% | 43.43% | 889.85% | - | 262.48% | 8998.77% | 183.66% | -184.67% | -102.49% | -121.06% | -93.8% | - |
| Book Value per Share | 0.39 | 0.44 | 0.33 | 0.44 | 0.23 | 0.34 | 0.78 | -17.44 | -1.32 | -41.28 | 15.12 | 149.18 |
| Total Shareholders' Equity | 23.19M | 20.93M | 16.78M | 19.45M | 9.86M | 14.59M | 1.7M | -6.07M | -164K | -2.03M | 731K | 7.16M |
| Common Stock | 63.58K | 59.34K | 51.26K | 49.91K | 43.68K | 42.32K | 7.64K | 6.81K | 10K | 2K | 2K | 6.56K |
| Retained Earnings | -148.72M | -141.18M | -134.42M | -127.32M | -117.79M | -111.12M | -162.05M | -93.32M | -155.54M | -154.51M | -151.38M | -77.87M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | -3.06M | 0 | 21K | 0 | 21K | 21K | 21K | 21K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |